Teclison Announces the Appointment of Wan Lung Eng as Chief Financial Officer
PRINCETON, N.J., Feb. 02, 2022 (GLOBE NEWSWIRE) — Teclison, a clinical-stage pharmaceutical company developing novel…
News
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
ZUG, Switzerland, and CAMBRIDGE, Mass., and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — CRISPR…
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, Feb. 02, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
TRACON Pharmaceuticals Announces Initiation of Randomized Phase 2 Trial of TRC102 in Lung Cancer Sponsored by the National Cancer Institute
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
Outlook Therapeutics to Present at the Fourth Annual Telluride Retina Film Festival
ISELIN, N.J., Feb. 02, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
ABVC BioPharma Announces Principal Investigator Meeting for Phase II Part 2 ADHD Clinical Study
Fremont, CA, Feb. 02, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC Biopharma, Inc. (NASDAQ:…
Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference
IRVINE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
VBL Therapeutics to Participate in the Guggenheim Oncology Conference and the 2022 BIO CEO & Investor Conference
TEL AVIV, Israel and NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq:…
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
SAN MATEO, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Bluejay Therapeutics, a private biopharmaceutical company…
Achieve Life Sciences Announces Participation in February Investor Conferences
SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Fate Therapeutics to Present at Upcoming February Investor Conferences
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Bolt Biotherapeutics to Participate in Upcoming February Conferences
REDWOOD CITY, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
PDS Biotech Announces Preliminary Efficacy Achievement in VERSATILE-002 Phase 2 Trial of PDS0101 in Combination With KEYTRUDA® (pembrolizumab) in Advanced Head and Neck Cancer
Achievement of initial efficacy milestone allows full enrollment of checkpoint inhibitor naïve cohort FLORHAM PARK,…
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 02, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled…
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
Lead STING inhibitor candidate, BBI-10, demonstrated dose-dependent cytokine reduction in nonclinical in vitro and in…
Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance
Projected revenue of $9M for fiscal 2022 through its Canadian and global operations, including the…
Medicenna to Announce Third Quarter Fiscal 2022 Financial Results and Operational Highlights on Wednesday, February 9, 2022
TORONTO and HOUSTON, Feb. 02, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at the Angiogenesis, Exudation, and Degeneration 2022 Virtual Conference on February 12, 2022
Clearside’s suprachoroidal space (SCS®) injection platform to be featured at top medical meeting and also…
Notified Expands Strategic Partnership with Nasdaq to Simplify ESG Data Management and Reporting for Customers
Agreement allows Notified to offer Nasdaq OneReport software to its Investor Relations, Public Relations, and…
Avid Unveils Avid NEXIS | EDGE to Power Post Production Workflows from Anywhere
Unique innovations enable content creation teams to collaborate without compromise and work from anywhere with…